thymopentin has been researched along with Leishmaniasis, American in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arcoleo, F; Cillari, E; Dieli, M; Gromo, G; Leoni, F; Liew, FY; Milano, S; Perego, R; Severn, A | 1 |
1 other study(ies) available for thymopentin and Leishmaniasis, American
| Article | Year |
|---|---|
Thymopentin reduces the susceptibility of aged mice to cutaneous leishmaniasis by modulating CD4 T-cell subsets.
Topics: Age Factors; Aging; Animals; CD4-Positive T-Lymphocytes; Disease Susceptibility; Female; Interferon-gamma; Interleukin-2; Interleukin-4; Leishmaniasis, Cutaneous; Lymph Nodes; Mice; Mice, Inbred BALB C; Spleen; Thymopentin; Time Factors | 1992 |